Medical progress: The challenge of HIV-1 subtype diversity

被引：400

作者：

Taylor, Barbara S. ^{[1
]}

Sobieszczyk, Magdalena E. ^{[1
]}

McCutchan, Francine E. ^{[1
]}

Hammer, Scott M. ^{[1
]}

机构：

[1] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 15期

关键词：

D O I：

10.1056/NEJMra0706737

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

HIV-1 has evolved multiple mechanisms to elude immune control. The view of virus as classifiable into distinct subtypes needs to reflect the reality of the constant emergence of new strains. This review discusses the implications of subtype diversity in HIV-1 for possible differential rates of disease progression, responses to antiretroviral therapy (including the development of resistance), and vaccine development. Copyright © 2008 Massachusetts Medical Society. All rights reserved.

引用

页码：1590 / 1602

页数：13

共 102 条

[1] Enfuvirtide binding domain is highly conserved in non-B HIV type 1 strains from Cameroon, West Central Africa [J].

Aghokeng, AF ;

Ewane, L ;

Awazi, B ;

Nanfack, A ;

Delaporte, E ;

Zekeng, L ;

Peeters, M .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (05) :430-433

[2] Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D [J].

Alaeus, A ;

Lidman, K ;

Björkman, A ;

Giesecke, J ;

Albert, J .

AIDS, 1999, 13 (08) :901-907

[3]

Alexander CS, 2002, ANTIVIR THER, V7, P31

[4] HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads [J].

Baeten, Jared M. ;

Chohan, Bhavna ;

Lavreys, Ludo ;

Chohan, Vrasha ;

McClelland, R. Scott ;

Certain, Laura ;

Mandaliya, Kishorchandra ;

Jaoko, Walter ;

Overbaugh, Julie .

JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (08) :1177-1180

[5] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination [J].

Barouch, DH ;

Santra, S ;

Schmitz, JE ;

Kuroda, MJ ;

Fu, TM ;

Wagner, W ;

Bilska, M ;

Craiu, A ;

Zheng, XX ;

Krivulka, GR ;

Beaudry, K ;

Lifton, MA ;

Nickerson, CE ;

Trigona, WL ;

Punt, K ;

Freed, DC ;

Guan, LM ;

Dubey, S ;

Casimiro, D ;

Simon, A ;

Davies, ME ;

Chastain, M ;

Strom, TB ;

Gelman, RS ;

Montefiori, DC ;

Lewis, MG ;

Emini, EA ;

Shiver, JW ;

Letvin, NL .

SCIENCE, 2000, 290 (5491) :486-492

[6] Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme [J].

Bellocchi, MC ;

Forbici, F ;

Palombi, L ;

Gori, C ;

Coelho, E ;

Svicher, V ;

D'Arrigo, R ;

Emberti-Gialloreti, L ;

Ceffa, S ;

Erba, F ;

Marazzi, MC ;

Silberstein, FC ;

Perno, CF .

JOURNAL OF MEDICAL VIROLOGY, 2005, 76 (04) :452-458

[7] A new classification for HIV-1 [J].

Berger, EA ;

Doms, RW ;

Fenyö, EM ;

Korber, BTM ;

Littman, DR ;

Moore, JP ;

Sattentau, QJ ;

Schuitemaker, H ;

Sodroski, J ;

Weiss, RA .

NATURE, 1998, 391 (6664) :240-240

[8] Human immunodeficiency virus superinfection and recombination: Current state of knowledge and potential clinical consequences [J].

Blackard, JT ;

Cohen, DE ;

Mayer, KH .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (08) :1108-1114

[9]

Bocket L, 2005, ANTIVIR THER, V10, P247

[10] HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture [J].

Brenner, Bluma G. ;

Oliveira, Maureen ;

Doualla-Bell, Florence ;

Moisi, Daniela D. ;

Ntemgwa, Michel ;

Frankel, Fernando ;

Essex, Max ;

Wainberg, Mark A. .

AIDS, 2006, 20 (09) :F9-F13

← 1 2 3 4 5 6 7 8 9 10 →